Filing Flows › Medicinova (MNOV) › Recalls, complaints & regulation
Medicinova (MNOV): clinical trials
Medicinova (MNOV) beyond its filings: 2 active clinical trials.
Medicinova's latest quarter
Medicinova, Q2 2026: revenue $458K (+241% year over year), operating margin -554.3%, net loss $2.3M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Medicinova have?
2 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.